Document is current

Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents?

Crossref DOI link: https://doi.org/10.1007/s00277-015-2519-4

Published Online: 2015-10-10

Published Print: 2016-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy